Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Allergan
|
| gptkbp:employees |
approximately 50,000
|
| gptkbp:founded |
gptkb:2013
|
| gptkbp:founder |
gptkb:Richard_A._Gonzalez
|
| gptkbp:headquarters |
gptkb:North_Chicago,_Illinois,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Abb Vie S.r.l.
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:parent_company |
gptkb:Abb_Vie_Inc.
|
| gptkbp:products |
gptkb:Humira
gptkb:Venclexta gptkb:Imbruvica |
| gptkbp:research_focus |
oncology
neuroscience immunology virology |
| gptkbp:revenue |
$56.1 billion (2022)
|
| gptkbp:subsidiary |
gptkb:Abb_Vie_Deutschland_Gmb_H_&_Co._KG
gptkb:Abb_Vie_Ltd. gptkb:Abb_Vie_S._A._S. |
| gptkbp:website |
www.abbvie.com
|
| gptkbp:bfsParent |
gptkb:Abb_Vie
|
| gptkbp:bfsLayer |
3
|